From Seekingalpha · · 40s
PTH: Caution Merited Given Weak Risk-Adjusted Returns
Investor warns PTH ETF's weak risk-adjusted returns warrant caution.
In brief
Investor warns PTH ETF's weak risk-adjusted returns warrant caution. Investor Vasily Zyryanov initiates coverage of PTH with a Hold rating due to poor risk-adjusted performance since 2014. Originally reported by Seekingalpha.
Investor initiates PTH coverage
Vasily Zyryanov initiates coverage of the Invesco Dorsey Wright Healthcare Momentum ETF with a Hold rating.
PTH's portfolio strength
PTH's biotechnology-heavy portfolio has strong weighted average Quant and Wall Street ratings.
Weak performance since 2014
PTH's performance since 2014 has been lackluster compared to IVV and XLV, especially in risk-adjusted returns and maximum drawdowns.
Questionable portfolio quality
PTH's portfolio has excessive exposure to EBITDA- and cash flow-negative companies.
The short version
Investor Vasily Zyryanov initiates coverage of PTH with a Hold rating due to poor risk-adjusted performance since 2014.
